Targeting CD38 with daratumumab for platelet transfusion refractoriness in aplastic anemia

Zhen Gao1,2,3, Hong Pan1,2,3, Lele Zhang1,2,3

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

Blood
|May 7, 2025
PubMed